Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964193 | Vaccine | 2015 | 10 Pages |
Abstract
The introduction of PCV13 would be a good value for money from the government perspective. It would represent a high-impact public health intervention for Egypt and respond to the National Immunization Technical Advisory Group (NITAG) resolution on reducing pneumonia burden and overall child mortality. Strengthening surveillance will be critical to generating high-quality national data, improving future economic analyses that support evidence-based decisions for introducing vaccines and public health interventions, and to monitoring their impact.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mohammed Sibak, Ibrahim Moussa, Nasr El-Tantawy, Shaza Badr, Irtaza Chaudhri, Essam Allam, Louise Baxter, Saiyed Abo Freikha, Céline Hoestlandt, Carlos Lara, Rana Hajjeh, Aline Munier,